A new Perspective in Science Bulletin explains why computational pathology must move beyond accurate algorithms. To help in real hospitals, AI tools need to be interpretable, reportable, cost-aware, and tested in routine clinical workflows.

Osaka Metropolitan University researchers found that participation in community gathering places was associated with a lower risk of cognitive disability among older adults without regular exercise habits. In this group, participants had about half the risk of developing cognitive disability compared with non-participants, whereas no such association was observed among older adults who already exercised regularly. 

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, will attend the conference and deliver two high-profile sessions—a panel discussion alongside top industry experts on "AI's Race to Reinvent Medicine", and a solo keynote address exploring "How to Address Diseases and Aging Simultaneously Using Frontier AI".

Extreme fatigue, a racing pulse, shortness of breath, brain fog, aching joints—the symptoms of long COVID can vary widely, change unpredictably, and be difficult to even recognize as signs of the condition. Long COVID also remains difficult to treat, as no standard treatments yet exist. To develop better care for long COVID, scientists need to understand what drives it. But its complex landscape of symptoms arises from equally complex biological mechanisms that may differ considerably from patient to patient. At Gladstone Institutes, new tools and discoveries are rapidly filling in the blanks. Most recently, researchers in the lab of Nadia Roan, PhD, found evidence that people with long COVID have distinctive changes in immune cells specialized to protect against the virus that causes long COVID, alongside similar changes in cells that protect against two herpesviruses. The findings appear in Cell Reports Medicine.